Get started
NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICALNANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICALNANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL

NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

603707 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is a holding company that engages in the research, development, manufacture and sale of biochemical pharmaceutical products. It offers injections such as heparin sodium, low molecular weight heparin, and heparin sodium raw material. The company was founded on October 16, 2000 and is headquartered in Nanjing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
603707 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company